BCLS II Investo (GP), LLC

10% owner at NewAmsterdam Pharma Co N.V. · on record since Dec 29, 2023
Director at Solid Biosciences Inc. · on record since Jan 12, 2024
10% owner at Xilio Therapeutics, Inc. · on record since Dec 10, 2021
10% owner at Solid Biosciences Inc. · on record since Dec 5, 2022

Insider trading activity of BCLS II Investo (GP), LLC

No transactions on record for BCLS II Investo (GP), LLC.

Track record of BCLS II Investo (GP), LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of BCLS II Investo (GP), LLC

Co-insiders of BCLS II Investo (GP), LLC

Bain Capital Life Sciences Fund II, L.P.NewAmsterdam Pharma Co N.V. +2
Bain Capital Life Sciences Investors II, LLCNewAmsterdam Pharma Co N.V. +2
Bain Capital Life Sciences Investors, LLCNewAmsterdam Pharma Co N.V. +2
BCIP Life Sciences Associates, LPNewAmsterdam Pharma Co N.V. +2
BCLS II Investco, LPNewAmsterdam Pharma Co N.V. +2
Adage Capital Management, L.P.Solid Biosciences Inc.
Alexandria Venture Investments, LLCXilio Therapeutics, Inc.
Amorrortu Pedro AlvaroSolid Biosciences Inc.
Arnold Matthew BennettSolid Biosciences Inc.
Atchinson RobertSolid Biosciences Inc.
Atlas Venture Associates Opportunity I, LLCXilio Therapeutics, Inc.
Atlas Venture Associates Opportunity I, L.P.Xilio Therapeutics, Inc.
Atlas Venture Associates XI, LLCXilio Therapeutics, Inc.
Atlas Venture Associates XI, L.P.Xilio Therapeutics, Inc.
Atlas Venture Fund XI, L.P.Xilio Therapeutics, Inc.
Atlas Venture Opportunity Fund I, L.P.Xilio Therapeutics, Inc.
Audet Juliette BerangereNewAmsterdam Pharma Co N.V.
Bain Capital Life Sciences Fund III, L.P.NewAmsterdam Pharma Co N.V.
Bain Capital Life Sciences III General Partner, LLCNewAmsterdam Pharma Co N.V.
Bain Capital Life Sciences Partners, LPSolid Biosciences Inc.
BAY CITY CAPITAL LLCXilio Therapeutics, Inc.
BCLS Fund III Investments GP, LLCNewAmsterdam Pharma Co N.V.
BCLS Fund III Investments, LPNewAmsterdam Pharma Co N.V.
BCLS II Equity Opportunities GP, LLCSolid Biosciences Inc.
BCLS II Equity Opportunities, LPSolid Biosciences Inc.
BCLS SB Investco, LPSolid Biosciences Inc.
Bello Akintunde OlatokumboXilio Therapeutics, Inc.
Blanchard Cheryl RXilio Therapeutics, Inc.
Bonstein SaraXilio Therapeutics, Inc.
Boxer Asset Management Inc.Solid Biosciences Inc.
Boxer Capital, LLCSolid Biosciences Inc.

This page republishes public regulatory disclosures.